Quality of life of patients with head and neck cancer after prophylactic percutaneous-gastrostomy

Eur J Clin Nutr. 2020 Apr;74(4):565-572. doi: 10.1038/s41430-019-0499-5. Epub 2019 Sep 30.

Abstract

Background: HNC patients often experience weight loss during treatment. To date, there is only limited data on patient quality of life (QLQ) and subjective benefit of the PEG insertion.

Objective: To investigate the nutritional status, QLQ, and overall benefit.

Methods: 181 patients fitting our inclusion criteria (01/2012-12/2012) were enrolled. Utilization rate, nutritional status, QLQ, and subjective PEG assessment were determined with electronic charts and the Quality of life-questionnaire (EORTC-QLQ-C30).

Results: The utilization rate of the entire cohort was 91.7%. The PEG was used full-time by 149 patients. No statistical differences in QLQ were observed between the groups. Of the patients that used the PEG entirely (99.7%), partially (85.3%) or not all (55.3%) would 99.7%, 85.3 and 55.8% undergo the procedure in the future if necessary.

Conclusions: QLQ was not significantly reduced by insertion. Especially patients using the PEG full-time had an objective and subjective benefit from the inserted PEG tube.

MeSH terms

  • Gastrostomy
  • Head and Neck Neoplasms* / surgery
  • Humans
  • Nutritional Status
  • Quality of Life*
  • Surveys and Questionnaires